MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-03-0003369
R K G Pharma Pvt Ltd - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹7.73 Cr
▲ 20% YoY
Net profit · FY 2025
₹1.88 Cr
Net margin 24.3%
EBITDA · FY 2025
₹2.64 Cr
EBITDA margin 34.1%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹30 Lakh
Issued & subscribed
Open charges
₹3.13 Cr
Satisfied ₹27 Lakh
Company age
57 yrs
Est. 1969
Employees · EPFO
22
Provident fund records
About R K G Pharma Pvt Ltd
Data last updated:
R K G Pharma Pvt Ltd is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 August 1969 and has been in existence for over 57 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1969PTC005111. Its GSTIN is 06AAACR4508H1ZM (Haryana). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹30 Lakh. It is led by directors Preeti Garg and Sanjeev Garg.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 125 First Floor Dayanand Colony Lajpat Nagar IV New Delhi., Delhi, India – 110024.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.73 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹1.88 Cr (net margin 24.3%) and EBITDA of ₹2.64 Cr (EBITDA margin 34.1%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years.
The company has about 22 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: RKG Pharma. As per MCA filings, the company has open charges of ₹3.13 Cr and satisfied charges of ₹27 Lakh on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it; 2 cases are pending.
R K G Pharma Pvt Ltd is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-03-0003369). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rkgpharmaindia.com.
Company Details of R K G Pharma Pvt Ltd
CIN U74899DL1969PTC005111
Registration Number 005111
Incorporation Date 16 August 1969
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HR-03-0003369
Key People
Preeti Garg Director Sanjeev Garg Director Recognitions & Rankings of R K G Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressC – 125 First Floor Dayanand Colony Lajpat Nagar IV New Delhi., Delhi, India – 110024
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
R K G Pharma Pvt Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with R K G Pharma Pvt Ltd
R K G Pharma operates one associated brand: RKG Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality pharmaceuticals including tablets, capsules, syrups, and injectables. | rkgpharmaindia.com |
Business Activity of R K G Pharma Pvt Ltd
The main business activity of R K G Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of R K G Pharma Pvt Ltd FY 2025 filings available
R K G Pharma Pvt Ltd reported revenue of ₹7.73 Cr (up 20% YoY) for FY 2025.
Revenue · FY 2025
₹7.73 Cr ▲ 20%
Net profit · FY 2025
₹1.88 Cr margin 24.3%
EBITDA · FY 2025
₹2.64 Cr margin 34.1%
Compounded Annual Growth Rate (CAGR) of R K G Pharma Pvt Ltd
Revenue CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▲ 94%
3 years · compounded
▲ 31%
5 years · compounded
▲ 24%
Revenue has grown at a compounded annual rate (CAGR) of 7% over three years, including 20% growth in the latest year. EBITDA rose 94% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of R K G Pharma Pvt Ltd
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.64 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.88 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of R K G Pharma Pvt Ltd
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 34.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 24.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of R K G Pharma are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of R K G Pharma Pvt Ltd
R K G Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Preeti Garg Also directs: Medlar Pharmachem Private Limited | Director | 15 Oct 2021 | 5 Years 0 Months | Current |
| Sanjeev Garg | Director | 01 Jun 1986 | 40 Years 4 Months | Current |
Peer Comparison of R K G Pharma Pvt Ltd
R K G Pharma Pvt Ltd is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Human Bio-Organics Private Limited | ₹7.74 Cr (FY 2024) | •••• | •••• | 42.0% | •••• | Thane, Maharashtra, India |
| Tychos Therapeutics Private Limited | ₹7.74 Cr (FY 2024) | •••• | •••• | -4.0% | •••• | Chennai, Tamil Nadu, India |
| Time Remedies Private Limited | ₹7.74 Cr (FY 2023) | •••• | •••• | -16.0% | •••• | Mumbai, Maharashtra, India |
| Alkon Formulation Private Limited | ₹7.74 Cr (FY 2024) | •••• | •••• | -30.0% | •••• | Baddi, Himachal Pradesh, India |
| Alathea Biotec Private Limited | ₹7.73 Cr (FY 2025) | •••• | •••• | 55.0% | •••• | Patna, Bihar, India |
| R K G Pharma Pvt Ltd this company | ₹7.73 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | New Delhi, Delhi, India |
| Suvishrhu Speciality Chemicals Private Limited | ₹7.72 Cr (FY 2024) | •••• | •••• | 125.0% | •••• | Thane, Maharashtra, India |
| Alchemist Remedies Private Limited | ₹7.72 Cr (FY 2025) | •••• | •••• | -38.0% | •••• | Indore, Madhya Pradesh, India |
| Ryzer Pharmaceutical Private Limited | ₹7.71 Cr (FY 2025) | •••• | •••• | 41.0% | •••• | Gandhinagar, Gujarat, India |
| Globespeciality Chemicals Private Limited | ₹7.71 Cr (FY 2025) | •••• | •••• | 167.0% | •••• | Pune, Maharashtra, India |
| Sunny Industries Pvt Ltd | ₹7.68 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below R K G Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of R K G Pharma Pvt Ltd
R K G Pharma Pvt Ltd is audited by BHATIA BEHL & ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| BHATIA BEHL & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of R K G Pharma Pvt Ltd
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of R K G Pharma Pvt Ltd
Open charges
₹3.13 Cr
Satisfied charges
₹27 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Apr 2005 | Dena Bank | ₹27 Lakh | Open |
| 14 Jan 2004 | Dena Bank | ₹80 Lakh | Open |
| 01 May 2000 | Dena Bank | ₹80 Lakh | Open |
| 06 Apr 2000 | Dena Bank | ₹1.1 Cr | Open |
| 29 Sep 1992 | Deena Bank | ₹4.6 Lakh | Open |
Total charge records: 10 View all charges
Legal Cases of R K G Pharma Pvt Ltd
R K G Pharma Pvt Ltd has 2 court cases on record: 1 filed by R K G Pharma, 1 filed against it. All cases are pending. Status as checked between 01 Oct 2026 and 02 Oct 2026.
Total cases
2
Filed by the company
1
Filed against the company
1
Pending
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 1 |
| District courts | 1 | 1 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chennai, Tamil Nadu | Criminal complaint | Filed against the company by an individual | Pending |
| High Court of Punjab and Haryana | Writ petition | Filed by the company against an individual | Pending |
Premium access
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at R K G Pharma Pvt Ltd
R K G Pharma Pvt Ltd has a workforce of 22 employees as of Apr 02, 2024.
Employee count
22
Active EPFO establishments
1
Employee growth
-4.35%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on R K G Pharma Pvt Ltd
R K G Pharma Pvt Ltd has 5 board changes on record since 1986: 2 appointments and 3 cessations. The latest: Mohinder Kumar Kapur ceased to be Director on 26 Dec 2021.
AGM
R K G Pharma Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
R K G Pharma Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Ceased
Mohinder Kumar Kapur ceased to be Director.
Ceased
Preeti Garg ceased to be Additional Director.
Appointed
Preeti Garg was appointed as Director.
Charges
A charge registered on 18 Apr 2005 via Charge ID 90059050 with Dena Bank was fully satisfied on 28 Oct 2020.
Ceased
Surendra Mohan Garg ceased to be Managing Director.
Charges
A charge with Dena Bank of Rs. 0.80 Cr registered on 01 May 2000 with Charge ID 90053900 was modified on 22 Jun 2006.
Charges
A charge with Dena Bank amounted to Rs. 0.27 Cr with Charge ID 90059050 was registered on 18 Apr 2005.
Charges
A charge with Dena Bank amounted to Rs. 0.27 Cr with Charge ID 90055704 was registered on 08 Apr 2005.
Charges
A charge with Dena Bank of Rs. 0.80 Cr registered on 14 Jan 2004 with Charge ID 90058380 was modified on 05 Jan 2005.
Charges
A charge with Dena Bank amounted to Rs. 0.80 Cr with Charge ID 90058380 was registered on 14 Jan 2004.
12 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for R K G Pharma Pvt Ltd
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by R K G Pharma Pvt Ltd
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of R K G Pharma Pvt Ltd
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of R K G Pharma Pvt Ltd
R K G Pharma has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAACR4508H1ZM | Haryana | Active | 01 Jul 2017 |
| 24AAACR4508H1ZO | Gujarat | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of R K G Pharma Pvt Ltd
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about R K G Pharma Pvt Ltd
R K G Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 August 1969 (57+ years old) and is registered under CIN U74899DL1969PTC005111.
R K G Pharma reported revenue of ₹7.73 Cr for FY 2025 (up 20% YoY).
R K G Pharma has 2 current directors:
- Preeti Garg - Director
- Sanjeev Garg - Director
R K G Pharma reported a net profit of ₹1.88 Cr (net margin 24.3%) and EBITDA of ₹2.64 Cr (EBITDA margin 34.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of R K G Pharma is 7% over three years. In the latest year (FY 2025) revenue rose 20%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of R K G Pharma is 06AAACR4508H1ZM, registered in Haryana. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 24AAACR4508H1ZO (Gujarat).
The CIN (Corporate Identification Number) of R K G Pharma is U74899DL1969PTC005111. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
R K G Pharma has 2 court cases on record: 1 filed by the company and 1 filed against it. 2 are pending. Most are in the high courts.
R K G Pharma was incorporated on 16 August 1969, making it 57+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of R K G Pharma by revenue are Human Bio-Organics Private Limited, Tychos Therapeutics Private Limited, Time Remedies Private Limited, Alkon Formulation Private Limited, Alathea Biotec Private Limited and 5 more, all in the Pharma industry (Formulations).
Mohinder Kumar Kapur ceased to be Director on 26 Dec 2021. Preeti Garg ceased to be Additional Director on 30 Nov 2021. Preeti Garg was appointed as Director on 15 Oct 2021. R K G Pharma has 5 board changes on record in total.